Mounjaro Flexpen 10 (Tirzepatide SOLUTION) 10mg

Mounjaro Flexpen 10 delivers tirzepatide in a pre-filled pen for type 2 diabetes management. This once-weekly injectable supports blood sugar control with convenient dosing. Ideal for adults seeking adjunct therapy to diet and exercise. Compact and portable for daily use.

Strength

10mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Lilly

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tirzepatide is prescribed to improve blood sugar levels in adults with type 2 diabetes. It works alongside diet and exercise to support glycemic control. Often used when oral medications alone are insufficient. May also aid weight management as part of a treatment plan.

Side Effects

Users often notice steadier energy levels throughout the day after starting tirzepatide. Appetite may decrease gradually, which can support weight goals. Some report improved overall well-being with consistent use. Effects vary by individual and may take several weeks to become noticeable.

Precautions & Warnings

Store the pen refrigerated between 2–8°C and protect from light. Avoid freezing or shaking vigorously. Keep pens dry and discard if damaged or expired. Always check the solution for particles or discoloration before use. Consult a healthcare provider if storage conditions are compromised.

Avoid Interactions

Alcohol may amplify blood sugar fluctuations when combined with tirzepatide. Certain medications like insulin or sulfonylureas can increase hypoglycemia risk. Always inform your doctor about all prescriptions and over-the-counter products. Some supplements or herbal remedies may also interact.

Frequently Asked Questions

Tirzepatide is used to improve blood sugar control in adults with type 2 diabetes alongside diet and exercise.

It is a once-weekly injection given under the skin, typically in the abdomen, thigh, or upper arm.

Weight changes may occur as a side effect, but it is not approved solely for weight management.

Common effects include nausea, diarrhea, or reduced appetite, especially when starting treatment.

Consult a healthcare provider; effects during pregnancy are not well studied in clinical trials.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.